Besides direct regulation of de novo serine/glycine synthesis, the cyclin D3:CDK4/6 complex has been described as an important indirect regulator in T-ALL through inhibition of glycolysis enzymes 6-phosphofructokinase (PFKP) and pyruvate kinase M2 (PKM2). Here, PFKP is linked to acute lymphoblastic leukemia.